Macular Degeneration (AMD)
Age Related Macular Degeneration (AMD) is a leading cause of vision loss in seniors in which the central portion of the retina, called the macula, is damaged as a result of the hardening of the small arteries supplying oxygen and nutrients to the retinal tissue. There are two main types of Age Related Macular Degeneration: Dry Macular Degeneration and Wet Macular Degeneration. Dry Macular Degeneration is the most common type of Age Related Macular Degeneration making up 85-90% of cases, resulting in a slow progressive loss of vision. Typically, we see small, yellow colored deposits between the retinal layers, which are called drusen. Many people 50 years of age or older have some drusen as they age and may be asked to schedule eye exams more frequently in order to monitor them as there is some possibility that Dry Macular Degeneration will progress to Wet Macular Degeneration. We need to detect Wet Macular Degeneration quickly as it has far more serious consequences for vision loss. Wet Macular Degeneration is characterized by an abnormal growth of new blood vessels under the retina, called “neovascularization,” which is prone to be leaky and can easily break and bleed. If leakage occurs, the macula may actually begin to swell, bleed and scar causing severe loss of central vision, which may be irreversible.
The retina specialists at Matossian Eye Associates perform in-office Age Related Macular Degeneration (AMD) exams, diagnostic testing and treatment including non-surgical retina injection treatment with Lucentis®, Eylea®, Beovu® or other medications if needed to help maintain your vision and prevent vision loss. With regular eye exams, early detection, diagnosis and treatment, vision loss from AMD can be halted in most instances.